Investors welcomed the news, with Tilray shares leaping nearly 10 percent on New York’s Nasdaq index as of 1530 GMT.
Canada pot grower Tilray enters pharma deal with Novartis’ Sandoz
More from Industry NewsMore posts in Industry News »
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya
- AstraZeneca launches Clinical Data and Insights division in India
- India’s 1 billion vaccines milestone hides a worrying disparity
- WHO-led programme aims to buy antiviral COVID-19 pills for $10
- Shortage of key TB drug stress patients; activists urge govt to issue compulsory license